January 15 2004–The global generics market is changing. A favorable environment in the US has lead to intense competition in commodity generics, and left players seeking alternative options to drive further growth. Meanwhile, regulatory reform in under penetrated EU generics markets is boosting generic usage, attracting attention from overseas players, and bringing with it its own set of challenges.

Scope

Benchmarking of leading generics players by 2002 sales, market share and financial position and by forecast ethical sales between 2003 and 2008

Analysis of portfolio management and geographic expansion strategies specific to US and EU based players

Full profiles of 11 leading generics players - Alpharma, Andrx, Barr, Biovail, IVAX, Mylan, Ranbaxy, SICOR, Stada, Teva, Watson

Report Highlights

The global generics market is forecast strong growth between 2003 and 2008. In the US, patent expiries will be the key driver, with $84 billion worth of 2002 blockbusters being at risk of generic competition by 2008. Europe is expected to outperform the US in terms of rate of growth in generics sales, with increased generic usage the key driver.

Despite the introduction of cost containment measures resulting in price cuts in mature generics markets such as the UK and Germany, the net benefit of regulatory reform and cost

In 2008, the best positioned generics companies will be those that have technology platforms enabling them to maintain margins in face of increased competition, and that have international manufacturing and distribution networks that allow them to profit from the growth potential in southern European markets.

This report is designed to:

Understand the drivers of growth in the major generics markets, and tailor your portfolio management strategy to maximize profit return

Benchmark your strategy against key rivals in the generics sector

Assess the impact of regulatory reform and increased generic penetration on the branded sector

For a complete index of this report click on http://www.researchandmarkets.com/reports/42622

About Research and Markets Ltd.
Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com